Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Nat Commun ; 11(1): 3501, 2020 07 09.
Article in English | MEDLINE | ID: mdl-32647108

ABSTRACT

While most monogenic diseases are caused by loss or reduction of protein function, the need for technologies that can selectively increase levels of protein in native tissues remains. Here we demonstrate that antisense-mediated modulation of pre-mRNA splicing can increase endogenous expression of full-length protein by preventing naturally occurring non-productive alternative splicing and promoting generation of productive mRNA. Bioinformatics analysis of RNA sequencing data identifies non-productive splicing events in 7,757 protein-coding human genes, of which 1,246 are disease-associated. Antisense oligonucleotides targeting multiple types of non-productive splicing events lead to increases in productive mRNA and protein in a dose-dependent manner in vitro. Moreover, intracerebroventricular injection of two antisense oligonucleotides in wild-type mice leads to a dose-dependent increase in productive mRNA and protein in the brain. The targeting of natural non-productive alternative splicing to upregulate expression from wild-type or hypomorphic alleles provides a unique approach to treating genetic diseases.


Subject(s)
Alternative Splicing , Gene Expression Regulation , Oligonucleotides, Antisense/pharmacology , Alleles , Animals , Animals, Newborn , Brain/metabolism , Computational Biology , Exons , Female , Gene Expression/drug effects , HEK293 Cells , Humans , Introns , Male , Mice , Mice, Inbred C57BL , RNA, Messenger/metabolism , Transcriptional Activation/drug effects , Up-Regulation
2.
Curr Biol ; 30(12): 2343-2352.e3, 2020 06 22.
Article in English | MEDLINE | ID: mdl-32470364

ABSTRACT

Maternally inherited RNA and proteins control much of embryonic development. The effect of such maternal information beyond embryonic development is largely unclear. Here, we report that maternal contribution of histone H3.3 assembly complexes can prevent the expression of late-onset anatomical, physiologic, and behavioral abnormalities of C. elegans. We show that mutants lacking hira-1, an evolutionarily conserved H3.3-deposition factor, have severe pleiotropic defects that manifest predominantly at adulthood. These late-onset defects can be maternally rescued, and maternally derived HIRA-1 protein can be detected in hira-1(-/-) progeny. Mitochondrial stress likely contributes to the late-onset defects, given that hira-1 mutants display mitochondrial stress, and the induction of mitochondrial stress results in at least some of the hira-1 late-onset abnormalities. A screen for mutants that mimic the hira-1 mutant phenotype identified PQN-80-a HIRA complex component, known as UBN1 in humans-and XNP-1-a second H3.3 chaperone, known as ATRX in humans. pqn-80 and xnp-1 abnormalities are also maternally rescued. Furthermore, mutants lacking histone H3.3 have a late-onset defect similar to a defect of hira-1, pqn-80, and xnp-1 mutants. These data demonstrate that H3.3 assembly complexes provide non-DNA-based heritable information that can markedly influence adult phenotype. We speculate that similar maternal effects might explain the missing heritability of late-onset human diseases, such as Alzheimer's disease, Parkinson's disease, and type 2 diabetes.


Subject(s)
Caenorhabditis elegans/physiology , Histones/genetics , Mutation , Nucleosomes/metabolism , Animals , Maternal Inheritance
3.
Curr Biol ; 28(10): 1522-1535.e5, 2018 05 21.
Article in English | MEDLINE | ID: mdl-29731301

ABSTRACT

The most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) is the expansion of a hexanucleotide repeat in a non-coding region of the gene C9orf72. We report that loss-of-function mutations in alfa-1, the Caenorhabditis elegans ortholog of C9orf72, cause a novel phenotypic defect: endocytosed yolk is abnormally released into the extra-embryonic space, resulting in refractile "blobs." The alfa-1 blob phenotype is partially rescued by the expression of the human C9orf72 protein, demonstrating that C9orf72 and alfa-1 function similarly. We show that alfa-1 and R144.5, which we identified from a genetic screen for mutants with the blob phenotype and renamed smcr-8, act in the degradation of endolysosomal content and subsequent lysosome reformation. The alfa-1 abnormality in lysosomal reformation results in a general dysregulation in lysosomal homeostasis, leading to defective degradation of phagosomal and autophagosomal contents. We suggest that, like alfa-1, C9orf72 functions in the degradation of endocytosed material and in the maintenance of lysosomal homeostasis. This previously undescribed function of C9orf72 explains a variety of disparate observations concerning the effects of mutations in C9orf72 and its homologs, including the abnormal accumulation of lysosomes and defective fusion of lysosomes to phagosomes. We suggest that aspects of the pathogenic and clinical features of ALS/FTD caused by C9orf72 mutations, such as altered immune responses, aggregation of autophagy targets, and excessive neuronal excitation, result from a reduction in C9orf72 gene function and consequent abnormalities in lysosomal degradation.


Subject(s)
Amyotrophic Lateral Sclerosis/genetics , Endosomes/physiology , Frontotemporal Dementia/genetics , Loss of Function Mutation/genetics , Lysosomes/physiology , Animals , Caenorhabditis elegans , Disease Models, Animal , Homeostasis
4.
Proc Natl Acad Sci U S A ; 110(30): E2802-11, 2013 Jul 23.
Article in English | MEDLINE | ID: mdl-23836656

ABSTRACT

Serine/arginine (SR) proteins, one of the major families of alternative-splicing regulators in Eukarya, have two types of RNA-recognition motifs (RRMs): a canonical RRM and a pseudo-RRM. Although pseudo-RRMs are crucial for activity of SR proteins, their mode of action was unknown. By solving the structure of the human SRSF1 pseudo-RRM bound to RNA, we discovered a very unusual and sequence-specific RNA-binding mode that is centered on one α-helix and does not involve the ß-sheet surface, which typically mediates RNA binding by RRMs. Remarkably, this mode of binding is conserved in all pseudo-RRMs tested. Furthermore, the isolated pseudo-RRM is sufficient to regulate splicing of about half of the SRSF1 target genes tested, and the bound α-helix is a pivotal element for this function. Our results strongly suggest that SR proteins with a pseudo-RRM frequently regulate splicing by competing with, rather than recruiting, spliceosome components, using solely this unusual RRM.


Subject(s)
Arginine/chemistry , Proteins/metabolism , RNA Splicing , RNA/metabolism , Serine/chemistry , Amino Acid Sequence , Binding Sites , Models, Molecular , Molecular Sequence Data , Proteins/chemistry
5.
Genes Dev ; 25(5): 445-59, 2011 Mar 01.
Article in English | MEDLINE | ID: mdl-21363963

ABSTRACT

Spliceostatin A (SSA) is a stabilized derivative of a Pseudomonas bacterial fermentation product that displays potent anti-proliferative and anti-tumor activities in cancer cells and animal models. The drug inhibits pre-mRNA splicing in vitro and in vivo and binds SF3b, a protein subcomplex of U2 small nuclear ribonucleoprotein (snRNP), which is essential for recognition of the pre-mRNA branch point. We report that SSA prevents interaction of an SF3b 155-kDa subunit with the pre-mRNA, concomitant with nonproductive recruitment of U2 snRNP to sequences 5' of the branch point. Differences in base-pairing potential with U2 snRNA in this region lead to different sensitivity of 3' splice sites to SSA, and to SSA-induced changes in alternative splicing. Indeed, rather than general splicing inhibition, splicing-sensitive microarray analyses reveal specific alternative splicing changes induced by the drug that significantly overlap with those induced by knockdown of SF3b 155. These changes lead to down-regulation of genes important for cell division, including cyclin A2 and Aurora A kinase, thus providing an explanation for the anti-proliferative effects of SSA. Our results reveal a mechanism that prevents nonproductive base-pairing interactions in the spliceosome, and highlight the regulatory and cancer therapeutic potential of perturbing the fidelity of splice site recognition.


Subject(s)
Alternative Splicing/drug effects , Antineoplastic Agents/pharmacology , Pyrans/pharmacology , Spiro Compounds/pharmacology , Cell Division/drug effects , Down-Regulation/drug effects , HeLa Cells , Humans , Phosphoproteins/metabolism , Protein Binding/drug effects , Protein Stability/drug effects , RNA Precursors/metabolism , RNA Splice Sites/drug effects , RNA Splicing Factors , Ribonucleoprotein, U2 Small Nuclear/metabolism , Spliceosomes/drug effects
6.
RNA ; 17(3): 401-11, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21233219

ABSTRACT

We report that the 3' splice site associated with the alternatively spliced exon 6 of the Fas receptor CD95 displays strict sequence requirements and that a mutation that disrupts this particular sequence arrangement leads to constitutive exon 6 skipping in a patient suffering from autoimmune lymphoproliferative syndrome (ALPS). Specifically, we find an absolute requirement for RCAG/G at the 3' splice site (where R represents purine, and / indicates the intron/exon boundary) and the balance between exon inclusion and skipping is exquisitely sensitive to single nucleotide variations in the uridine content of the upstream polypyrimidine (Py)-tract. Biochemical experiments revealed that the ALPS patient mutation reduces U2 snRNP recruitment to the 3' splice site region and that this effect cannot be explained by decreased interaction with the U2 snRNP Auxiliary Factor U2AF, whose 65- and 35-kDa subunits recognize the Py-tract and 3' splice site AG, respectively. The effect of the mutation, which generates a tandem of two consecutive AG dinucleotides at the 3' splice site, can be suppressed by increasing the distance between the AGs, mutating the natural 3' splice site AG or increasing the uridine content of the Py-tract at a position distal from the 3' splice site. The suppressive effects of these additional mutations correlate with increased recruitment of U2 snRNP but not with U2AF binding, again suggesting that the strict architecture of Fas intron 5 3' splice site region is tuned to regulate alternative exon inclusion through modulation of U2 snRNP assembly after U2AF binding.


Subject(s)
Autoimmune Lymphoproliferative Syndrome/etiology , Cell Nucleus/genetics , Nuclear Proteins/metabolism , RNA Precursors/genetics , RNA Splicing/genetics , Ribonucleoprotein, U2 Small Nuclear/metabolism , Ribonucleoproteins/metabolism , fas Receptor/genetics , Autoimmune Lymphoproliferative Syndrome/pathology , Cross-Linking Reagents/pharmacology , HeLa Cells , Humans , Immunoprecipitation , Mutation/genetics , Nuclear Proteins/genetics , Ribonucleoprotein, U2 Small Nuclear/genetics , Ribonucleoproteins/genetics , Splicing Factor U2AF , fas Receptor/metabolism
7.
Mol Cell ; 36(6): 918-9, 2009 Dec 25.
Article in English | MEDLINE | ID: mdl-20064456

ABSTRACT

Using genome-wide RNA-binding data, Xue et al. (2009) draw a regulatory map in this issue of Molecular Cell for the much-studied polypyrimidine tract-binding protein (PTB) that reveals a unique paradigm in posttranscriptional gene regulation.


Subject(s)
RNA Processing, Post-Transcriptional , RNA Splicing , RNA, Messenger , Gene Expression Profiling , Gene Expression Regulation , HeLa Cells , Humans , Polypyrimidine Tract-Binding Protein/genetics , Polypyrimidine Tract-Binding Protein/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...